BioNTech says they can make a mutation vaccination in 6 weeks – THE WORLD – ANOTHER

BERLIN: The co-founder of BioNTech said on Tuesday that it was “very likely” that its anti-virus vaccine works against the strain of measles found in Britain, but it could also change the vaccine if that is necessary in six weeks.

“Scientifically, it is very likely that the immune response with this vaccine can counteract the new virus,” Ugur Sahin said.

But if need be, “in principle the beauty of the messenger technology is that we can start directly to design a vaccine that is completely similar to this new trend – we may be able to deliver a new vaccine. technically within six weeks. “

Sahin said the variant found in Britain has nine mutations, instead of just one as usual.

However, he encouraged confidence that the vaccine developed by Pfizer would be effective as it contains “more than 1,000 amino acids, of which only nine have changed, so that is 99 per cent of the protein remains the same “.

He said tests are being run on the contrary, with results expected in two weeks.

“We have scientific confidence that the vaccine could protect but we will only know if the test is carried out … we will publish the data as soon as possible,” he said.